BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28577199)

  • 1. Urine Incontinence Induced by Valproic Acid.
    Sudan YS; Bansal AR
    Indian J Pediatr; 2017 Nov; 84(11):867-868. PubMed ID: 28577199
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible dementia and gait disturbance after prolonged use of valproic acid.
    Evans MD; Shinar R; Yaari R
    Seizure; 2011 Jul; 20(6):509-11. PubMed ID: 21435910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate induced isolated neutropenia.
    Kohli U; Gulati S
    Indian J Pediatr; 2006 Sep; 73(9):844. PubMed ID: 17006050
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized onycholysis associated with sodium valproate therapy.
    Grech V; Vella C
    Eur Neurol; 1999 Jul; 42(1):64-5. PubMed ID: 10523137
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor VII deficiency associated with valproate treatment.
    Unalp A; Dirik E; Kurul S
    Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the immunosuppressive effect of some anticonvulsants in children].
    Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L
    Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible cognitive and neurological symptoms during valproic acid therapy.
    Hommet C; Mondon K; de Toffol B; Constans T
    J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced pseudoatrophy: expanding the clinical and imaging spectrum.
    Lovett M; Skidmore DL; Mohamed IS
    Pediatr Neurol; 2014 Aug; 51(2):284-5. PubMed ID: 25079580
    [No Abstract]   [Full Text] [Related]  

  • 9. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
    Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
    J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of chronic pancreatic insufficiency due to valproic acid in a child.
    Cooper MA; Groll A
    Can J Gastroenterol; 2001 Feb; 15(2):127-30. PubMed ID: 11240383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute Intermittent porphyria and valproic acid].
    Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
    Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate-induced worsening of seizures: clue to underlying diagnosis.
    Dhamija R; Gavrilova RH; Wirrell EC
    J Child Neurol; 2011 Oct; 26(10):1319-21. PubMed ID: 21454832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
    Pokorná P; Hronová K; Šíma M; Slanař O; Klement P; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2017 May; 73(5):647-649. PubMed ID: 28168312
    [No Abstract]   [Full Text] [Related]  

  • 17. Gaze-evoked nystagmus associated with valproic acid-induced lamotrigine toxicity.
    Jung I; Shin JH; Kim J
    Clin Neurol Neurosurg; 2020 Sep; 196():106013. PubMed ID: 32623210
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoalbuminemia with valproic acid administration.
    Rugino TA; Janvier YM; Baunach JM; Bilat CA
    Pediatr Neurol; 2003 Nov; 29(5):440-4. PubMed ID: 14684241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermia and thermoregulatory derangements induced by valproic acid.
    Nagarajan L; Johnston K; Williams S
    Neurology; 2001 Jan; 56(1):139. PubMed ID: 11148261
    [No Abstract]   [Full Text] [Related]  

  • 20. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.